EUVIMEDEUVIMED entdecken
Crossref

CB1 receptor antagonism reverses social and cognitive deficits induced by repeated exposure to distressed conspecifics in rats

Fatemeh Rahimi Shourmasti, Seyedeh Masoumeh Seyedhosseini Tamijani, Raheleh Rafaiee, Mehdi Khodamoradi, Mohammad Shabani, Fatemeh Mohammadi, Abolhassan Ghaderi, Hamed Ghazvini

Neuroscience Letters · 2025

DOI: 10.1016/j.neulet.2025.138299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroscience Letters, 2025. Verfasst von Fatemeh Rahimi Shourmasti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Social Behavior, Empathy, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Empathy is a behavioral phenomenon characterized by the capacity to share in another individual's distressing experiences, including pain, discrimination, and social rejection. The cannabinoid system, recognized as one of the brain's neuromodulatory systems, appears to play a significant role in social and prosocial behaviors, particularly in the context of empathy. This study aimed to investigate the potential role of the cannabinoid system in mediating empathic pain and behavior, an area that has not been thoroughly explored to date. To this end, an empathic pain model was employed, wherein pain was socially transmitted from a sibling demonstrator, who received five formalin injections, to a sibling observer. Naïve observer rats were administered either the cannabinoid type 1 receptor (CB1R) antagonist rimonabant (1 mg/kg, i.p.) or the CB1R agonist WIN 55,212-2 (WIN; 3 mg/kg, i.p.) 30 min prior to behavioral assessments. The animals were subsequently evaluated using tail-flick and social interaction tasks. The behavioral findings revealed that both the demonstrator and observer groups exhibited significant increases in hyperalgesia and impairments in social memory. Notably, the administration of rimonabant, but not WIN, partially restored cognitive functions and induced analgesia in the observer rats. Furthermore, hippocampal levels of brain-derived neurotrophic factor (BDNF) decreased in both demonstrator and observer rats, whereas rimonabant administration resulted in an increase in BDNF levels in the hippocampus, in contrast to WIN. These results suggest that the CB1R may be intricately involved in prosocial behavior and emotional contagion, potentially through the modulation of BDNF levels in the hippocampus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Social BehaviorEmpathyCognitive DysfunctionCannabinoid Receptor AntagonistsAnimalsMaleRimonabantRatsBrain-Derived Neurotrophic FactorNaphthalenesMorpholinesBenzoxazinesHyperalgesiaHippocampusBehavior, AnimalRats, WistarPain

Stichwörter der Autor:innen

Cannabinoid systemEmpathyRimonabantSocial interactionWIN 55,212-2

Substanzen

Receptor, Cannabinoid, CB1Rimonabant(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneBrain-Derived Neurotrophic FactorNaphthalenesMorpholinesBenzoxazinesCannabinoid Receptor AntagonistsBdnf protein, rat

Autor:innen und Institutionen

  • Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Substance Abuse Prevention Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
  • Department of Basic Sciences, Sirjan School of Medical Sciences, Sirjan, Iran.
  • Clinical Research Development Unit, lmam Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
  • Department of Neuroscience, School of Advanced Technologies in Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran Univers…

Zitieren

APA

Shourmasti, F. R., Seyedhosseini Tamijani, S. M., Rafaiee, R., Khodamoradi, M., Shabani, M., Mohammadi, F., Ghaderi, A., & Ghazvini, H. (2025). CB1 receptor antagonism reverses social and cognitive deficits induced by repeated exposure to distressed conspecifics in rats. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2025.138299

Vancouver

Shourmasti FR, Seyedhosseini Tamijani SM, Rafaiee R, Khodamoradi M, Shabani M, Mohammadi F, et al. CB1 receptor antagonism reverses social and cognitive deficits induced by repeated exposure to distressed conspecifics in rats. Neuroscience Letters. 2025. doi:10.1016/j.neulet.2025.138299

BibTeX
@article{Shourmasti2025,
  author = {Shourmasti, Fatemeh Rahimi and Seyedhosseini Tamijani, Seyedeh Masoumeh and Rafaiee, Raheleh and Khodamoradi, Mehdi and Shabani, Mohammad and Mohammadi, Fatemeh and Ghaderi, Abolhassan and Ghazvini, Hamed},
  title = {CB1 receptor antagonism reverses social and cognitive deficits induced by repeated exposure to distressed conspecifics in rats},
  journal = {Neuroscience Letters},
  year = {2025},
  doi = {10.1016/j.neulet.2025.138299}
}
Kostenlos starten →